OTC Medicines

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act.

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

CHPA, the PCPC, and their member companies are aligned with FDA, CDC, the U.S. Surgeon General, and other health professionals worldwide about the important health benefits sunscreens provide as part of a safe sun regimen.

PCPC, the CHPA, and their member companies are aligned with FDA, CDC, the U.S. Surgeon General, AAD, the Skin Cancer Foundation and health professionals worldwide about the important health benefits sunscreens provide as part of a safe sun regimen to help prevent sunburn and reduce skin cancer risk.

Acetaminophen was chosen for review by OEHHA in part because the Prop 65 regulation emphasizes chemicals with “widespread exposure.” The Carcinogen Identification Committee will review the information on acetaminophen and cancer to determine whether acetaminophen should be listed as a carcinogen under Proposition 65.

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.